Yttrium-90 ibritumomab tiuxetan
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Yttrium-90 ibritumomab tiuxetan, covering 2012-04-03 to 2021-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients [Phase 1, Phase 2]